Perioperative Management of Patients with Severe Diabetes Requiring Anesthesia
For patients with severe diabetes requiring anesthesia, elective surgery should be postponed if HbA1c is >8% or blood glucose is >16.5 mmol/L (297 mg/dL) on the day of surgery, with referral to a diabetologist for optimization; however, emergency surgery should proceed regardless of glucose control with intensive intraoperative insulin protocols targeting blood glucose of 5.6-10.0 mmol/L (100-180 mg/dL). 1, 2
Preoperative Assessment and Risk Stratification
Glycemic Control Evaluation
- Obtain a recent HbA1c measurement for all diabetic patients, as this is essential for determining perioperative risk and should guide clearance decisions 2
- Target HbA1c should be <8% (63.9 mmol/L) for elective surgeries whenever possible 1
- If HbA1c is between 6-8%, this indicates adequate control and the patient can be cleared for anesthesia with standard perioperative glucose monitoring 2
- For HbA1c >8% in non-urgent procedures, postpone surgery and refer to a diabetologist for optimization 2
- If blood glucose is >16.5 mmol/L (297 mg/dL) on the day of surgery, postpone elective procedures, administer corrective insulin bolus, and refer to diabetologist 1, 2
Cardiovascular and Autonomic Assessment
- Perform preoperative risk assessment for ischemic heart disease in patients at high risk, particularly those with autonomic neuropathy or renal failure 1
- Screen for silent myocardial ischemia through ECG, as this is present in 30-50% of type 2 diabetes patients, and consider stress testing if major surgery with Lee score ≥2 3
- Evaluate for cardiac autonomic neuropathy through orthostatic blood pressure changes and heart rate variability, as this increases sudden death risk 1, 3
Additional Complications Screening
- Assess for gastroparesis by questioning about abdominal pain, bloating, and vomiting, as this creates aspiration risk requiring rapid sequence induction 3
- Evaluate for difficult intubation using the palm print test, as long-term diabetes causes densification of periarticular collagen structures affecting temporomandibular and atlanto-occipital joints 1
- Measure glomerular filtration rate preoperatively, as diabetic nephropathy increases acute renal failure risk 3
- Screen for recent hypoglycemic episodes (blood glucose <3.9 mmol/L) in the last week, as these predict perioperative risk 3
Medication Management
Oral Hypoglycemic Agents
- Hold metformin on the day of surgery due to lactic acidosis risk, particularly in patients with renal failure (creatinine clearance <60 mL/min), severe heart failure, or those receiving iodinated contrast agents 1
- Do not restart metformin before 48 hours for major surgery and only after assuring adequate renal function 1
- Discontinue SGLT2 inhibitors 3-4 days before surgery to prevent euglycemic diabetic ketoacidosis 1
- Hold all other oral glucose-lowering agents the morning of surgery or procedure 1
Insulin Management
- Give half of NPH dose or 75-80% doses of long-acting analog insulin on the morning of surgery based on the type of diabetes and clinical judgment 1
- For insulin pump users, understand the "total basal delivery" preoperatively to allow prescription of long-acting insulin if the pump must be stopped 1
- For ambulatory or short-duration surgery, retain the insulin pump to continue basal delivery, with correction of hyperglycemia using subcutaneous ultra-rapid analog boluses 1
- The main risk with insulin pumps is ketoacidosis if continuation of insulin is not immediate after stopping the pump, requiring either subcutaneous basal-bolus or continuous intravenous insulin 1
Intraoperative Management
Blood Glucose Targets and Monitoring
- Target blood glucose range of 100-180 mg/dL (5.6-10.0 mmol/L) within 4 hours of surgery 1
- Monitor blood glucose at least every 2-4 hours while the patient takes nothing by mouth 1
- For lengthy surgeries, monitor capillary blood glucose hourly during the procedure 2
- Perioperative hyperglycemia >180 mg/dL (10 mmol/L) increases morbidity and mortality, particularly from infection 3
- Hyperglycemia >250 mg/dL (13.9 mmol/L) carries significantly higher complication risk 3, 4
Insulin Administration
- Use continuous IV insulin infusion via electronic syringe for patients requiring insulin or experiencing stress hyperglycemia 3
- Administer short- or rapid-acting insulin as needed for blood glucose control 1
- If blood glucose exceeds 10 mmol/L (180 mg/dL), administer ultra-rapid analogue insulin bolus 2
- In noncardiac general surgery patients, basal insulin plus premeal short- or rapid-acting insulin (basal-bolus) coverage is associated with improved glycemic outcomes and lower rates of perioperative complications compared with correction-only insulin 1
- Poor intraoperative glycemic control (defined as four consecutive blood glucose concentrations >200 mg/dL despite insulin therapy) is associated with a 7.2-fold increased odds of severe postoperative morbidity 5
Glucose Infusion
- Set up glucose infusion (starting from 7:00 AM) if the patient needs to fast while treated with insulin 1
- Stop glucose infusion if blood glucose exceeds 16.5 mmol/L (297 mg/dL) 1
- Patients taking sulfonylureas or glinides before emergency surgery also require glucose infusion if remaining fasted 1
Anesthetic Considerations
- No specific anesthetic agent has been proven superior for diabetic patients 1
- Prioritize regional anesthesia when possible for superior postoperative pain control and reduced insulin resistance 3
- Regional anesthesia is not contraindicated but requires careful preoperative documentation of pre-existing polyneuropathy and dysautonomia 1
- Both intravenous and perineural dexamethasone administration is associated with increased blood glucose levels, requiring consideration of risk-benefit ratio 6
Postoperative Management
Immediate Recovery Period
- Continue hourly capillary blood glucose monitoring until the patient is fully conscious and capable of self-management 3
- Maintain glucose infusion (10% dextrose at 40 mL/h) for insulin-dependent patients to prevent recurrent hypoglycemia 3
- Resume oral feeding as soon as possible postoperatively 2
- Continue regular blood glucose monitoring postoperatively 2
Insulin Resumption
- Resume insulin pump basal infusion once the patient can manage their device and is eating 3
- Start bolus insulin dosing with first postoperative carbohydrate ingestion 3
- Evidence indicates that reducing insulin given the evening before surgery by 25% (compared with usual dosing) is more likely to achieve perioperative blood glucose levels in target range with lower hypoglycemia risk 1
Hypoglycemia Management
- Capillary glucose <3.3 mmol/L represents significant hypoglycemia requiring immediate treatment, regardless of clinical signs 7
- For patients with altered consciousness unable to swallow, administer IV glucose immediately 7
- After initial glucose administration, continue regular monitoring to ensure recovery and detect recurrence 7
- Be aware that 40% of type 1 diabetes and 10% of insulin-treated type 2 diabetes patients have hypoglycemia unawareness, requiring more vigilant monitoring 3
Critical Pitfalls to Avoid
- Do not aim for strict normoglycemia (tighter than 80-180 mg/dL), as perioperative glycemic targets tighter than this range do not improve outcomes and are associated with more hypoglycemia 1, 3
- Never stop insulin pumps without immediate IV insulin replacement in type 1 diabetes patients, as ketoacidosis develops within hours 3
- Do not use continuous glucose monitor (CGM) readings for intraoperative glucose management due to lag time and perfusion-dependent inaccuracy 3
- Avoid assuming drowsiness is solely due to post-surgical sedation—always check glucose in any post-surgical patient with altered mental status 7
- Do not delay glucose administration while waiting for additional symptoms to develop—hypoglycemia <3.3 mmol/L requires immediate treatment even without clinical signs 7
When to Consult Endocrinology
- Referral to a diabetologist is recommended for known diabetes with preoperative glycemic imbalance (HbA1c <5% or >8%), diabetes discovered during pre-anesthesia evaluation, blood glucose >16.5 mmol/L on day of surgery, or difficulty resuming previous treatment regimen 2